Skip to content
The Biotechnology Innovation Organization (BIO) Patient and Health Advocacy Summit returns to an in-person format for the first time since before the COVID-19 pandemic—and […]
What to know about the BIO Patient and Health Advocacy Summit Read More »
The World Health Organization (WHO) published the first list of fungal priority pathogens yesterday, identifying 19 fungi “that represent the greatest threat to public
WHO releases first-ever list of fungal priority pathogens Read More »
The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the
U.S. biotech is a major economic driver with a broad range, report says Read More »
The Biotechnology Innovation Organization (BIO), the Developing Countries Vaccine Manufacturers Network (DCVMN), and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) announced a
Biotechs offer governments ‘a practical solution to vaccine equity’ Read More »
Echoing a bipartisan Senate letter last week, two top House trade leaders are raising serious concerns about the proposed expansion of the World Trade Organization (WTO)
House leaders speak out on COVID IP waiver expansion Read More »
The Advisory Committee on Immunization Practices (ACIP), the CDC’s panel of independent vaccination advisers, yesterday recommended adding COVID-19 vaccines to the list of recommended
CDC committee recommends adding COVID vaccines to routine immunization schedules Read More »
October 20 is World CRISPR Day, commemorating the day CRISPR was first used to edit a human genome, marking a new era in history.
World CRISPR Day celebrates transformative technology’s impact Read More »
The FDA on Tuesday announced it had “issued an emergency use authorization (EUA) for the first over-the-counter molecular test authorized for use with saliva
FDA grants EUA to over-the-counter molecular test for COVID-19 Read More »
BIO member company Ginkgo Bioworks has partnered with the U.S. Intelligence Advanced Research Projects Activity (IARPA) to utilize the company’s synthetic biology technology for
The most recent illustration of the strength of patient advocacy is the FDA’s approval of new ALS medicine, which was developed with $2 million
Podcast tells of patient advocates improving drug development Read More »
